
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ipamorelin is a selective growth hormone-releasing peptide (GHRP) that stimulates growth hormone release by binding to ghrelin receptors in the pituitary gland. This pentapeptide promotes muscle growth, fat loss, and recovery without significantly affecting cortisol or prolactin levels.

Reported Benefits (Provisional)
Origin & History

Ipamorelin is a synthetic peptide that mimics the action of ghrelin, a natural hormone. It is produced through peptide synthesis and is used primarily for its growth hormone-releasing properties.
Research Narrative (Provisional)
Ipamorelin has been studied in animal models and early human trials, showing potential for growth hormone release and muscle growth. More research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Composed of a sequence of amino acids. - Administered via subcutaneous injection. - Acts on the pituitary gland to release growth hormone.
Reported Mechanism (Provisional)
Ipamorelin binds selectively to growth hormone secretagogue receptors (GHS-R1a) in the anterior pituitary gland, triggering the release of endogenous growth hormone. Unlike other GHRPs, it demonstrates high selectivity for GH release without stimulating ACTH, cortisol, or prolactin secretion. The peptide mimics ghrelin's action but with greater specificity, leading to pulsatile GH release that follows natural circadian rhythms.
Clinical Narrative (Provisional)
Human studies on ipamorelin are limited, with most research conducted in animal models and small-scale clinical trials. A study in elderly adults (n=24) showed significant increases in growth hormone levels within 30 minutes of administration, with peak levels occurring at 45-60 minutes. Animal studies demonstrate improved body composition, with 15-20% increases in lean muscle mass and 10-15% reductions in body fat over 8-12 week periods. The current evidence suggests efficacy but requires larger, longer-term human trials for definitive clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







